Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 NALIDIXIC ACID IN URINARY INFECTIONS.

Literature DB >> 14058207

NALIDIXIC ACID IN URINARY INFECTIONS.

J F WARD-MCQUAID, D JICHLINSKI, R MACIS.

Abstract

Entities: Chemical

Keywords: DOGS; DRUG RESISTANCE, MICROBIAL; ESCHERICHIA COLI INFECTIONS; EXPERIMENTAL LAB STUDY; KLEBSIELLA; MICE; MONKEYS; NAPHTHYRIDINES; PHARMACOLOGY; PROTEUS INFECTIONS; RATS; STAPHYLOCOCCAL INFECTIONS; STREPTOCOCCAL INFECTIONS; TOXICOLOGIC REPORT; URINARY TRACT INFECTIONS

Mesh：

Substances：

Year: 1963 PMID： 14058207 PMCID： PMC1873444 DOI： 10.1136/bmj.2.5368.1311

Source DB: PubMed Journal: Br Med J ISSN： 0007-1447

× No keyword cloud information.

9 in total

1. 1,8-NAPHTHYRIDINE DERIVATIVES. A NEW CLASS OF CHEMOTHERAPEUTIC AGENTS.

Authors: G Y LESHER; E J FROELICH; M D GRUETT; J H BAILEY; R P BRUNDAGE
Journal: J Med Pharm Chem Date: 1962-09

2. NALIDIXIC ACID IN INFECTIONS OF URINARY TRACT. LABORATORY AND CLINICAL INVESTIGATIONS.

Authors: A M BARLOW
Journal: Br Med J Date: 1963-11-23

3. Chemotherapeutic and antibiotic drugs in the management of infections of the urinary tract.

Authors: E H KASS
Journal: Am J Med Date: 1955-05 Impact factor: 4.965

4. A misapplication of the sensitivity test. Mandelamine discs.

Authors: P M WATERWORTH
Journal: J Med Lab Technol Date: 1962-07

5. A clinical trial of the treatment of gram-negative urinary infections with nalidixic acid.

Authors: R M JAMESON; J SWINNEY
Journal: Br J Urol Date: 1963-06

6. Failure of prolonged treatment of chronic urinary-tract infections with antibiotics.

Authors: M TURCK; A A BROWDER; R I LINDEMEYER; K N BROWN NK ANDERSON; R G PETERSDORF
Journal: N Engl J Med Date: 1962-11-15 Impact factor: 91.245

7. The results of chemotherapy in urinary infections.

Authors: L P GARROD; R A SHOOTER; M P CURWEN
Journal: Br Med J Date: 1954-10-30

8. Antibacterial management of urinary tract infections.

Authors: P S RHOADS; C E BILLINGS; V J O'CONOR
Journal: J Am Med Assoc Date: 1952-01-19

9. NEGGRAM (NALIDIXIC ACID): A NEW ANTIMICROBIAL CHEMOTHERAPEUTIC AGENT.

Authors: G CARROLL
Journal: J Urol Date: 1963-10 Impact factor: 7.450

9 in total

11 in total

1. TREATMENT OF GONORRHOEA WITH NALIDIXIC ACID.

Authors: L Z OLLER
Journal: Br J Vener Dis Date: 1964-12

2. A COMPARATIVE STUDY OF THE LEVELS OF NALIDIXIC ACID IN PLASMA AND URINE AND ITS ANTIBACTERIAL ACTIVITY IN URINARY INFECTIONS OF PARAPLEGICS.

Authors: N O GIBBON; J G BENSTEAD; G C MISRA
Journal: Postgrad Med J Date: 1965-08 Impact factor: 2.401

NALIDIXIC ACID IN URINARY INFECTIONS.

1. 1,8-NAPHTHYRIDINE DERIVATIVES. A NEW CLASS OF CHEMOTHERAPEUTIC AGENTS.

2. NALIDIXIC ACID IN INFECTIONS OF URINARY TRACT. LABORATORY AND CLINICAL INVESTIGATIONS.

3. Chemotherapeutic and antibiotic drugs in the management of infections of the urinary tract.

4. A misapplication of the sensitivity test. Mandelamine discs.

5. A clinical trial of the treatment of gram-negative urinary infections with nalidixic acid.

6. Failure of prolonged treatment of chronic urinary-tract infections with antibiotics.

7. The results of chemotherapy in urinary infections.

8. Antibacterial management of urinary tract infections.

9. NEGGRAM (NALIDIXIC ACID): A NEW ANTIMICROBIAL CHEMOTHERAPEUTIC AGENT.

1. TREATMENT OF GONORRHOEA WITH NALIDIXIC ACID.

2. A COMPARATIVE STUDY OF THE LEVELS OF NALIDIXIC ACID IN PLASMA AND URINE AND ITS ANTIBACTERIAL ACTIVITY IN URINARY INFECTIONS OF PARAPLEGICS.

3. A CLINICAL TRIAL WITH NALIDIXIC ACID ON 22 ACUTE AND CHRONIC URINARY TRACT INFECTIONS WITH FOLLOW-UP FOR 1-5 MONTHS.

4. TISSUE CONCENTRATION OF NALIDIXIC ACID IN CHRONIC PYELONEPHRITIS.

5. Nalidixic Acid: microbiological and clinical studies on urinary infections in children.

6. The choice of anti-microbial therapy in urinary infections in children.

7. Factors governing the emergence of resistance to nalidixic acid in treatment of urinary tract infection.

8. Induction of bacteriophage lambda with oxolinic and nalidixic acid.

9. Drug sensitivity of Proteus species.

10. Today's drugs. Nalidixic acid.